{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:49Z","timestamp":1761129529273,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PB-PG-1014-35007"],"award-info":[{"award-number":["PB-PG-1014-35007"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204809\/Z\/16\/Z"],"award-info":[{"award-number":["204809\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000374","name":"British Medical Association","doi-asserted-by":"publisher","award":["TP Gunton 2017"],"award-info":[{"award-number":["TP Gunton 2017"]}],"id":[{"id":"10.13039\/501100000374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2674-8","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T09:44:59Z","timestamp":1528191899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u2018Test n Treat (TnT)\u2019\u2013 Rapid testing and same-day, on-site treatment to reduce rates of chlamydia in sexually active further education college students: study protocol for a cluster randomised feasibility trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Sarah","family":"Kerry-Barnard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vari M.","family":"Drennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Majewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjella","family":"Balendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Harding-Esch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tariq Sadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-8211","authenticated-orcid":false,"given":"Pippa","family":"Oakeshott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"2674_CR1","doi-asserted-by":"publisher","first-page":"e4168","DOI":"10.1136\/bmj.e4168","volume":"344","author":"P Oakeshott","year":"2012","unstructured":"Oakeshott P, Aghaizu A, Reid F, Howell-Jones R, Hay PE, Sadiq ST, et al. Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study. BMJ. 2012;344:e4168.","journal-title":"BMJ"},{"key":"2674_CR2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1086\/656739","volume":"51","author":"P Oakeshott","year":"2010","unstructured":"Oakeshott P, Aghaizu A, Hay P, Reid F, Kerry S, Atherton H, et al. Is Mycoplasma genitaliium in women the \u2018new chlamydia\u2019? Community-based prospective cohort study. Clin Infect Dis. 2010;51:1160\u20136.","journal-title":"Clin Infect Dis"},{"key":"2674_CR3","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/bmj.c1642","volume":"340","author":"P Oakeshott","year":"2010","unstructured":"Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Br Med J. 2010;340:1642.","journal-title":"Br Med J"},{"key":"2674_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/sextrans-2014-051607","volume":"90","author":"A Aghaizu","year":"2014","unstructured":"Aghaizu A, Reid F, Kerry S, Hay PE, Mallinson H, Jensen JS, et al. Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study. Sex Transm Infect. 2014;90:524\u20138.","journal-title":"Sex Transm Infect"},{"key":"2674_CR5","first-page":"1","volume-title":"Getting more young women screened for chlamydia: findings from qualitative research","author":"National Chlamydia Coalition","year":"2011","unstructured":"National Chlamydia Coalition. Getting more young women screened for chlamydia: findings from qualitative research, vol. 3; 2011. p. 1\u201317."},{"key":"2674_CR6","volume-title":"Opportunistic chlamydia screening of young adults in England","author":"Public Health England","year":"2014","unstructured":"Public Health England. Opportunistic chlamydia screening of young adults in England. London: Public Health England; 2014."},{"key":"2674_CR7","doi-asserted-by":"publisher","first-page":"e4316","DOI":"10.1136\/bmj.e4316","volume":"345","author":"IV van den Broek","year":"2012","unstructured":"van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Gotz HM, Hoebe CJ, et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ. 2012;345:e4316.","journal-title":"BMJ"},{"issue":"7","key":"2674_CR8","doi-asserted-by":"publisher","first-page":"e005322","DOI":"10.1136\/bmjopen-2014-005322","volume":"4","author":"EJ Adams","year":"2014","unstructured":"Adams EJ, Ehrlich A, Turner KM, Shah K, Macleod J, Goldenberg S, et al. Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK. BMJ Open. 2014;4(7):e005322.","journal-title":"BMJ Open"},{"issue":"2","key":"2674_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/sextrans-2013-051147","volume":"90","author":"KM Turner","year":"2014","unstructured":"Turner KM, Round J, Horner P, Macleod J, Goldenberg S, Deol A, et al. An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. Sex Transm Infect. 2014;90(2):104\u201311.","journal-title":"Sex Transm Infect"},{"issue":"6","key":"2674_CR10","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1128\/JCM.03461-12","volume":"51","author":"CA Gaydos","year":"2013","unstructured":"Gaydos CA, Van Der Pol B, Jett-Goheen M, Barnes M, Quinn N, Clark C, et al. Performance of the Cepheid CT\/NG Xpert Rapid PCR Test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2013;51(6):1666\u201372.","journal-title":"J Clin Microbiol"},{"key":"2674_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/1471-2334-13-485","volume":"13","author":"RJ Guy","year":"2013","unstructured":"Guy RJ, Natoli L, Ward J, Causer L, Hengel B, Whiley D, et al. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the \u2018TTANGO\u2019 trial protocol. BMC Infect Dis. 2013;13:485.","journal-title":"BMC Infect Dis"},{"key":"2674_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1745-6215-9-73","volume":"9","author":"P Oakeshott","year":"2008","unstructured":"Oakeshott P, Kerry S, Atherton H, Aghaizu A, Hay S, Taylor-Robinson D, et al. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention Of Pelvic Infection) trial. Trials. 2008;9:73.","journal-title":"Trials"},{"key":"2674_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/hex.12354","volume":"19","author":"R Normansell","year":"2016","unstructured":"Normansell R, Drennan V, Oakeshott P. Exploring female FE college students\u2019 attitudes to regular sexually transmitted infection screening: a qualitative study. Health Expect. 2016;19:322\u201330. PMC5055273","journal-title":"Health Expect"},{"issue":"4","key":"2674_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/sextrans-2012-050567","volume":"88","author":"J Ellis","year":"2012","unstructured":"Ellis J, Green R, Kerry SR, Jesuratnam G, Rajamanoharan A, Patel R, et al. Acceptability of providing self-taken vaginal samples and allowing access to NHS numbers and medical records: feasibility study in young female genitourinary medicine clinic attenders. Sex Transm Infect. 2012;88(4):300.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"2674_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/1471-2334-13-379","volume":"13","author":"JS Hocking","year":"2013","unstructured":"Hocking JS, Vodstrcil L, Huston WM, Timms P, Chen M, Worthington K, et al. A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol. BMC Infect Dis. 2013;13(1):379.","journal-title":"BMC Infect Dis"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1136\/sextrans-2013-051151","volume":"89","author":"T Hunjan","year":"2013","unstructured":"Hunjan T, Kerry SR, Hay P, Planche T, Sadiq ST, Oakeshott P. Chlamydia testing: where are we now? Recruiting high risk women to a pilot STI screening trial. Sex Trans Infect. 2013;89:556.","journal-title":"Sex Trans Infect"},{"issue":"4","key":"2674_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/sti.2010.048694","volume":"87","author":"A Aghaizu","year":"2011","unstructured":"Aghaizu A, Adams EJ, Turner K, Kerry S, Hay P, Simms I, et al. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial. Sex Transm Infect. 2011;87(4):312\u20137.","journal-title":"Sex Transm Infect"},{"key":"2674_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1745-6215-15-264","volume":"15","author":"MD Teare","year":"2014","unstructured":"Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;15:264.","journal-title":"Trials"},{"key":"2674_CR19","doi-asserted-by":"crossref","unstructured":"Phillips R, Reid F. Test n Treat statistical analysis plan. \"Test n Treat\": a cluster randomised feasibility trial of frequent rapid testing and same day on-site treatment to reduce rates of chlamydia in further education college students. Trials. [in press] 2018.","DOI":"10.1186\/s13063-018-2675-7"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2674-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2674-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2674-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T19:13:36Z","timestamp":1559675616000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2674-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2674-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"26 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Bromley REC reference 15\/LO\/1929. All participants will provide informed written consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Pippa Oakeshott is a member of the NIHR South London Collaboration for Leadership in Applied Health Research and Care. PO, STS, EHE, and EC are members of the esti2 consortium funded under the UKCRC Translational Infection Research Initiative supported by the Medical Research Council (Grant Number G0901608) with contributions from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"311"}}